Cargando…
Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
OBJECTIVE: To explore the effect of Ludangshen oral liquid for treatment of convalescent patients with coronavirus disease 2019 (COVID-19) with randomized, double-blind, placebo-controlled multicenter method. METHODS: 200 convalescent COVID-19 patients who had symptoms related to decreased digestive...
Autores principales: | An, Xuedong, Peng, Bo, Huang, Xiaodong, Jiang, Hongmei, Xiong, Zhang’e, Zhang, Hong, Lian, Fengmei, Ba, Yuanming, Tong, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976166/ https://www.ncbi.nlm.nih.gov/pubmed/35366928 http://dx.doi.org/10.1186/s13020-022-00602-x |
Ejemplares similares
-
Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial
por: Zheng, Yujiao, et al.
Publicado: (2022) -
Efficacy of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled, Parallel-Arm, Multi-Center Trial
por: Zhang, Yuehong, et al.
Publicado: (2021) -
The Efficacy and Safety of Chinese Herbal Medicine Jinlida as Add-On Medication in Type 2 Diabetes Patients Ineffectively Managed by Metformin Monotherapy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial
por: Lian, Fengmei, et al.
Publicado: (2015) -
The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine
por: Jiang, Linlin, et al.
Publicado: (2023) -
Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
por: Weishaar, Kristen M., et al.
Publicado: (2021)